Genomic aberrations in borderline ovarian tumors

Area of Science:

• Gynecologic Oncology
• Cancer Genetics
• Ovarian Pathology

Background:

• Limited karyotyping and genomic imbalance analysis exist for borderline ovarian tumors.
• Understanding genetic alterations in borderline ovarian tumors is crucial for predicting progression.

Purpose of the Study:

• To investigate chromosomal aberrations and genomic imbalances in borderline ovarian tumors.
• To explore the relationship between genetic alterations and tumor bilaterality.
• To assess the potential for malignant transformation in borderline ovarian tumors.

Main Methods:

• Karyotyping and G-banding on 23 borderline ovarian tumors.
• High-resolution comparative genomic hybridization (CGH) for genomic imbalances.
• Microsatellite analysis and fluorescence in situ hybridization (FISH) for specific deletions.

Main Results:

• Common chromosomal aberrations include gains of +7 and +12.
• Frequent copy number changes involve gains on 2q, 6q, 8q, 9p, 13q and losses on 1p, 12q, 14q, 15q, 16p, 17p, 17q, 19p, 19q, 22q.
• Bilateral tumors showed more aberrations than unilateral ones, suggesting metastatic spread.

Conclusions:

• Some genomic imbalances in borderline ovarian tumors resemble those in ovarian carcinomas, indicating a subset may progress to malignancy.
• Borderline tumors with detectable genetic alterations might have a higher propensity for clonal evolution and malignant transformation.
• Tumors lacking genetic imbalances may have a lower risk of progressing to invasive carcinomas.